ICRM
BHC icon

Insight Capital Research & Management’s Bausch Health BHC Stock Holding History

Insight Capital Research & Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,382
Closed -$2.53M – 91
2015
Q2 		$2.53M Buy
+11,382
New +$2.52M 0.67% 67
2013
Q4 		– Sell
-5,766
Closed -$610K – 142
2013
Q3 		$610K Sell
5,766
-4,701
-45% -$458K 0.15% 122
2013
Q2 		$901K Buy
+10,467
New +$825K 0.23% 117

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Insight Capital Research & Management's BHC Position: Q3 2015 in Review

Insight Capital Research & Management sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 11,382 shares — an estimated $2.53M sold.

Insight Capital Research & Management first reported a position in BHC in Q2 2013 and held it in 3 quarters. The position peaked at $2.53M in Q2 2015. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

  • Insight Capital Research & Management reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
  • Insight Capital Research & Management sold 11,382 Bausch Health shares in Q3 2015, an estimated $2.53M.
  • Insight Capital Research & Management first reported a position in Bausch Health in Q2 2013 and held it in 3 quarters.
  • Insight Capital Research & Management's Bausch Health position peaked at $2.53M in Q2 2015.
  • 546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Insight Capital Research & Management's 13F filing for Q3 2015, filed 5 Nov 2015.